Susan M. Schader

742 total citations
18 papers, 618 citations indexed

About

Susan M. Schader is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Susan M. Schader has authored 18 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 17 papers in Virology and 3 papers in Molecular Biology. Recurrent topics in Susan M. Schader's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (13 papers). Susan M. Schader is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (15 papers) and HIV/AIDS Research and Interventions (13 papers). Susan M. Schader collaborates with scholars based in Canada, United States and South Korea. Susan M. Schader's co-authors include Mark A. Wainberg, Maureen Oliveira, Min Lu, Per Johan Klasse, John P. Moore, Thomas J. Ketas, Susan P. Colby-Germinario, Ronald S. Veazey, Jason Dufour and Qinxue Hu and has published in prestigious journals such as Nature, Antimicrobial Agents and Chemotherapy and Virology.

In The Last Decade

Susan M. Schader

18 papers receiving 604 citations

Peers

Countries citing papers authored by Susan M. Schader

Since Specialization

Citations

This map shows the geographic impact of Susan M. Schader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Schader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Schader more than expected).

Fields of papers citing papers by Susan M. Schader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan M. Schader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Schader. The network helps show where Susan M. Schader may publish in the future.

Co-authorship network of co-authors of Susan M. Schader

This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Schader. A scholar is included among the top collaborators of Susan M. Schader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Schader. Susan M. Schader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Novel Compound Inhibitors of HIV-1NL4-3 Vpu 2022 ·Viruses ·Carolyn Robinson, Terri D. Lyddon, (unknown), David T. Evans, (unknown), Jonathan Richard, Andrés Finzi, Sarah Welbourn, Lynn Rasmussen, (unknown), (unknown), (unknown), Zhaohui Cai, Elizabeth R. Wonderlich, Corinne E. Augelli‐Szafran, Robert Bostwick, Roger G. Ptak, Susan M. Schader, Marc C. Johnson	4
2	Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation 2022 ·ACS Infectious Diseases ·Lori A. Emert‐Sedlak, Omar Moukha‐Chafiq, Haibin Shi, Shoucheng Du, John J. Alvarado, Vibha Pathak, (unknown), R. Hunter, (unknown), Li Chen, Tatiana V. Ilina, Rieko Ishima, Sixue Zhang, (unknown), Elizabeth R. Wonderlich, Susan M. Schader, Corinne E. Augelli‐Szafran, Roger G. Ptak, Thomas E. Smithgall	9
3	Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors 2022 ·Viruses ·Sonia Mediouni, (unknown), Susan M. Schader, Susana T. Valente	14
4	Differential regulatory activities of viral protein X for anti-viral efficacy of nucleos(t)ide reverse transcriptase inhibitors in monocyte-derived macrophages and activated CD4+ T cells 2015 ·Virology ·Joseph A. Hollenbaugh, Susan M. Schader, Raymond F. Schinazi, Baek Kim	5
5	HIV-1 Subtype Variability in Vif Derived from Molecular Clones Affects APOBEC3G-Mediated Host Restriction 2013 ·Intervirology ·(unknown), Susan M. Schader, Richard D. Sloan, Maureen Oliveira, Dimitrios Coutsinos, Nicole F. Bernard, Mark A. Wainberg	9
6	Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine 2013 ·Antimicrobial Agents and Chemotherapy ·Hongtao Xu, Susan P. Colby-Germinario, Eugene L. Asahchop, Maureen Oliveira, Matthew McCallum, Susan M. Schader, Ying-Shan Han, Yudong Quan, Stefan G. Sarafianos, Mark A. Wainberg	61
7	HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug 2012 ·Antimicrobial Agents and Chemotherapy ·Susan M. Schader, Susan P. Colby-Germinario, Peter K. Quashie, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, Daniela Moïsi, Thibault Mésplède, Mark A. Wainberg	28
8	Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load 2012 ·Antimicrobial Agents and Chemotherapy ·Victor G. Kramer, Susan M. Schader, Maureen Oliveira, Susan P. Colby-Germinario, Daniel A. Donahue, Diane N. Singhroy, (unknown), Richard D. Sloan, Mark A. Wainberg	23
9	Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination 2011 ·AIDS ·Susan M. Schader, Susan P. Colby-Germinario, (unknown), Hongtao Xu, Mark A. Wainberg	33
10	Insights into HIV-1 pathogenesis through drug discovery: 30 years of basic research and concerns for the future 2011 ·HIV & AIDS Review ·Susan M. Schader, Mark A. Wainberg	5
11	In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine 2011 ·Antimicrobial Agents and Chemotherapy ·Susan M. Schader, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, Daniela Moïsi, Susan P. Colby-Germinario, Mark A. Wainberg	38
12	HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes 2010 ·Antimicrobial Agents and Chemotherapy ·(unknown), Susan M. Schader, (unknown), Maureen Oliveira, Daniela Moïsi, Mark A. Wainberg	18
13	The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity 2010 ·Antimicrobial Agents and Chemotherapy ·Hongtao Xu, Yudong Quan, Susan M. Schader, Maureen Oliveira, Tamara Bar-Magen, Mark A. Wainberg	22
14	Human Immunodeficiency Virus Type 1 Recombinant Reverse Transcriptase Enzymes Containing the G190A and Y181C Resistance Mutations Remain Sensitive to Etravirine 2009 ·Antimicrobial Agents and Chemotherapy ·Hongtao Xu, Yudong Quan, Bluma Brenner, Tamara Bar-Magen, Maureen Oliveira, Susan M. Schader, Mark A. Wainberg	16
15	Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture 2009 ·Antimicrobial Agents and Chemotherapy ·Daniel A. Donahue, Richard D. Sloan, Björn D. Kuhl, Tamara Bar-Magen, Susan M. Schader, Mark A. Wainberg	42
16	Benefits of an educational program for journalists on media coverage of HIV/AIDS in developing countries 2008 ·Journal of the International AIDS Society ·Jorge Martínez-Cajas, Cédric Invernizzi, Michel Ntemgwa, Susan M. Schader, Mark A. Wainberg	8
17	Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes 2007 ·Virology ·Thomas J. Ketas, Susan M. Schader, Juan Zurita, (unknown), Victoria R. Polonis, Min Lu, Per Johan Klasse, John P. Moore	28
18	Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusion 2005 ·Nature ·Ronald S. Veazey, Per Johan Klasse, Susan M. Schader, Qinxue Hu, Thomas J. Ketas, Min Lu, Preston A. Marx, Jason Dufour, Richard J. Colonno, Robin J. Shattock, Martin S. Springer, John P. Moore	255

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact